INS and inflammatory bowel disease: In terms of laboratory results, IBD-MASLD patients showed higher triglyceride levels (121 ± 55 vs. 81 ± 17 mg/dL, p = 0.001), fasting blood glucose (94 ± 23 vs. 83 ± 8 mg/dL, p = 0.019), fasting insulin (12 ± 9 vs. 7 ± 2 mg/dL, p = 0.001), and homeostasis model assessment of insulin resistance (HOMA-IR; 3 ± 2 vs. 1.5 ± 0.45 mg/dL, p = 0.002).